Sonoma Pharmaceuticals, Inc. , develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally.
Sonoma Pharmaceuticals stock last closed at $2.22, down 3.48% from the previous day, and has decreased 29.48% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.27 percentage points. Sonoma Pharmaceuticals stock is currently +26.86% from its 52-week low of $1.75, and -76.32% from its 52-week high of $9.37.
There are currently 1.62M shares of SNOA outstanding. The market value of SNOA is $3.59M. In the past 24 hours, 45,353 SNOA shares were traded.
You need an online brokerage account to access the NASDAQ market and buy SNOA shares.
We believe that eToro is the best stock brokerage. eToro gives you:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you'll need to fill out some personal details so you can invest in SNOA stock today.
Now that you have finished signing up on the best stock market app for beginners, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring money into your new brokerage account.
After you have decided on the best place to buy Sonoma Pharmaceuticals stock, it's critical to analyze their stock before you buy, so you actually understand the risk and upside.
WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SNOA's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge SNOA's fair value.
Using relative valuations methods:
You can do more valuation analysis on SNOA's stock here.
You can dig deeper into what analysts are saying on the Sonoma Pharmaceuticals stock forecast page.
Last year, SNOA revenue was $13.97M. Over the past 5 year, SNOA's revenue has increased by -4.94% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 7.89%.
Find out more about SNOA's earnings and revenue performance here.
In the past 12 months, insiders at SNOA have not bought or sold any shares.
Learn more about who owns SNOA stock here.
No, Sonoma Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main options:
Press the Open Trade button and eToro will execute the order.
If you need more help with investing in stocks on eToro, watch the helpful video below:
Now that you own some SNOA stock, you'll want to stay up-to-date on your investment.
Make a watchlist to track the latest developments regarding your SNOA stock.
To reiterate, here are the 6 steps to buy Sonoma Pharmaceuticals stock:
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Sonoma Pharmaceuticals, click below.